Current concepts in estrogen replacement therapy in the menopause
Fertility and SterilityPublished 1 February 1993
Donna R. Session, Amalia C. Kelly, Raphael Jewelewicz
Citations65
SJR quartileQ1
SJR score2.03
SNIP2.05
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Replacement therapy is effective in treating symptoms of estrogen deficiency and in lowering the risk of osteoporosis and cardiovascular disease, and new therapeutic regimens and modes of delivery decrease risk and increase patient acceptance of hormonal replacement therapy.
Abstract
New therapeutic regimens and modes of delivery decrease risk and increase patient acceptance of hormonal replacement therapy.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
CirculationCardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.
1,364 Citations1987Trudy L. Bush, E. Barrett-Connor +6 more
New England Journal of MedicineAssociation of Exogenous Estrogen and Endometrial Carcinoma
961 Citations1975Donald C. Smith, Ross L. Prentice +2 more
Exogenous estrogen therapy is associated with an increased risk of endometrial carcinoma, but this increased relative risk is less apparent in patients with physiologic characteristics previously associated with a increased risk, and was highest in patients without obesity and hypertension.
New England Journal of MedicineA Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease
855 Citations1985Meir J. Stampfer, Walter C. Willett +4 more
The hypothesis that the postmenopausal use of estrogen reduces the risk of severe coronary heart disease is supported.
Journal of the American Medical AssociationPOSTMENOPAUSAL OSTEOPOROSIS
833 Citations1941Fuller Albright, Patricia H. Smith +1 more
The existence of postmenopausal osteoporosis is pointed out and its clinical features described and some metabolic data showing the effects of therapy with estrogens and other agents are incorporated in other papers.
New England Journal of MedicineDecreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
786 Citations1980Noel S. Weiss, Carol L. Ure +3 more
It is argued that lowering of the risk of hip and forearm fractures must be weighed as a benefit of long-term estrogen use.
Annals of Internal MedicineQuantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy
660 Citations1982Harry K. Genant, CHRISTOPHER E. CANN +2 more
The results indicate that spinal quantitative computed tomography provides a highly sensitive measurement of bone mineral loss after oophorectomy, that bone Mineral loss is five- to sevenfold greater from the spinal spongiosum than from the appendicular cortex, and that conjugated estrogen in doses of less than 0.6 mg/d are inadequate to prevent the vertebral mineral loss.
JAMAA Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer
635 Citations1991Karen Steinberg
To quantify the effect of estrogen replacement therapy on breast cancer risk, a combined dose-response slopes of the relative risk of breast cancer against the duration of estrogen use across 16 studies was combined.
Archives of Internal MedicineDecreased Mortality in Users of Estrogen Replacement Therapy
634 Citations1991B. E. Henderson
New England Journal of MedicineThe Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement
617 Citations1989Leif Bergkvist, Hans‐Olov Adami +3 more
In this cohort, long-term perimenopausal treatment with estrogens (or at least estradiol compounds) seems to be associated with a slightly increased risk of breast cancer, which is not prevented and may even be increased by the addition of progestins.
European Journal of Clinical InvestigationPrevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females
604 Citations1980Claus Christiansen, Merete Sanvig Christensen +4 more
This study randomized 315 healthy volunteers in their early natural menopause to seven treatment and three placebo groups, with the aim of preventing postmenopausal bone loss.
Clinical Orthopaedics and Related ResearchOn Aging Bone Loss
546 Citations1982Richard B. Mazess
The findings suggest that the common assumption about a large ongoing loss of trabecular bone after menopause may be erroneous, as are the implications of the findings for calcium metabolism, anatomical correlations and fracture incidences.
New England Journal of MedicineBiologic Effects of Transdermal Estradiol
467 Citations1986Ryszard J. Chetkowski, David R. Meldrum +8 more
Obstetrics and GynecologyEstrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems
451 Citations1979Lila E. Nachtigall, R. Nachtigall +2 more
Results revealed no statistically significant difference in that incidence of thrombophlebitis, myocardial infarction (MI), or uterine cancer, and patients in the treated group who began the study with elevated beta/alpha lipoprotein ratios showed a reduction in that ratio over the course of the study.
Journal of Epidemiology & Community HealthThe menopausal syndrome
435 Citations1974Sonja M. McKinlay, Margot Jefferys
Results of a postal questionnaire survey of 638 women aged 45 to 54, living in the London area in 1964-65, indicate that hot flushes and night sweats are clearly associated with the onset of a natural menopause and that they occur in the majority of women.
New England Journal of MedicineEffects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium
399 Citations1981MI Whitehead, P. T. Townsend +3 more
It is concluded that many estrogen preparations subject the endometrium to a potent stimulus, and norethindrone and norgestrel are protective because they counteract the proliferative effects of estrogens, but the currently recommended daily dosages of these progestins can be greatly reduced without loss of response.
PubMedEstrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.
374 Citations1979Lila E. Nachtigall, R. Nachtigall +2 more
Estrogen-treated patients whose therapy started within 3 years of menopause showed improvement or no increase in osteoporosis, while control patients demonstrate an increase in their osteopsorosis.
American Journal of Obstetrics and GynecologyEffects of long-term estrogen replacement therapy
372 Citations1979Charles B. Hammond, Frederick R. Jelovsek +3 more
The long-term administration of estrogen to these relatively young women with hypoestrogenism was associated with significantly lower rates of development of cardiovascular disease, hypertension, osteoporosis, and fractures and an increase in the likelihood of developing adenocarcinoma of the endometrium.
Archives of Internal MedicineMenopausal Estrogen Replacement Therapy and Breast Cancer
370 Citations1991William D. Dupont
The combined results from multiple studies provide strong evidence that menopausal therapy consisting of 0.625 mg/d or less of conjugated estrogens does not increase breast cancer risk.
New England Journal of MedicineEffects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy
352 Citations1981E Hirvonen, Marjatta Mälkönen +1 more
The results suggest that the androgenic hormone estradiol with medroxyprogesterone acetate was not associated with a significant change in HDL cholesterol and high-density-lipoprotein (HDL) cholesterol decreased by 20 per cent from the base-line level during treatment with both the Estradiol-norethindrone acetate and estradio-norgestrel regimens.
BMJPostmenopausal oestrogen treatment and stroke: a prospective study.
349 Citations1988Annlia Paganini‐Hill, Rachael K. Ross +1 more
Oestrogen replacement treatment protects against death due to stroke in all age groups except the youngest and was unaffected by adjustment for possible confounding factors.
MaturitasInfluence of menopause on serum lipids and lipoproteins
339 Citations1990Jan H. Jensen, Lisbeth Nilas +1 more
Serum lipids and lipoproteins are significantly altered as a consequence of the menopause, resulting in a more atherogenic lipid profile which may partly explain the increased risk of cardiovascular disease observed in post-menopausal women.
New England Journal of MedicineMenopausal Estrogens and Breast Cancer
337 Citations1976Robert N. Hoover, Laman A. Gray +2 more
Estrogen use was related to an especially high risk of breast cancer among women in whom benign disease developed after they had started the drug, and the excess risk after 10 years was not due simply to prolonged estrogen use, since there was no clear dose-response relation to accumulated years of use.
EndocrinologyControl of Uterine Estrogen Receptor Levels by Progesterone
310 Citations1976Aaron J.W. Hsueh, Ernest J. Peck +1 more
It is suggested that progesterone and other estrogen antagonists such as nafoxidine and testosterone propionate inhibit estrogen action by interfering with the replenishment of Rc, thereby reducing the number of receptor estrogen complexes that are translocated and retained by uterine nuclei.
New England Journal of MedicineReplacement Estrogens and Endometrial Cancer
279 Citations1979Hershel Jick, Richard N. Watkins +5 more
The drop in overall incidence soon after estrogen use declined suggests that the increased risk associated with estrogens falls quickly after discontinuation, and was part of a general decline in the United States after 1975.
The LancetEffects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women
278 Citations1990John C. Stevenson, MP Cust +7 more
British Journal of CancerMenopausal oestrogens and breast cancer risk: An expanded case-control study
254 Citations1986L A Brinton, R. N. Hoover +1 more
Findings support a role for oestrogens in the aetiology of breast cancer, although risk appears to be enhanced only after extended periods of use, and not to the extent observed for other hormonally-sensitive tumours.
American Journal of Obstetrics and GynecologyEstrogen replacement therapy and protection from acute myocardial infarction
236 Citations1988Brian E. Henderson, Annlia Paganini‐Hill +1 more
As part of a longitudinal study of a southern California retirement community begun in June 1981, 8841 women 44 to 101 years old completed a health survey questionnaire, and as of January 1, 1987, 1019 deaths had occurred among these women.
PubMedTreatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
217 Citations1991Andrew J. Friedman, D I Hoffman +3 more
The LancetASSOCIATIONS OF SERUM HIGH DENSITY LIPOPROTEIN AND TOTAL CHOLESTEROL WITH TOTAL, CARDIOVASCULAR, AND CANCER MORTALITY IN A 7-YEAR PROSPECTIVE STUDY OF 10 000 MEN
212 Citations1981Shaul Yaari
Results indicate that, particularly in older age-groups, measures designed to increase HDL cholesterol may prove as valuable in preventing CHD as those designed to reduce low density lipoprotein cholesterol.
American Journal of Obstetrics and GynecologySubfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: A comparison between progestogens and natural progesterone
192 Citations1985U.B. Ottosson, BRITT‐MARIE JOHANSSON +1 more
D doses and relative biologic activity of 19-norsteroids and 17-hydroxyprogesterone derivatives are more important for their metabolic effects than are qualitative differences and natural progesterone had no apparent influence on high-density lipoprotein cholesterol or its subfractions and may develop into an attractive alternative to synthetic progestogens.
Archives of Internal MedicineEstrogen replacement therapy. A survey of women's knowledge and attitudes
190 Citations1989Kathya Ferguson
Assessment of women's attitudes toward ERT suggested that a systematic educational approach could influence women's willingness to take ERT, especially if the recommended therapy does not cause withdrawal bleeding.
BMJEndometrial disease after treatment with oestrogens and progestogens in the climacteric.
183 Citations1980M E Paterson, T. Wade‐Evans +3 more
The absence of vaginal bleeding or of a regular bleeding response does not guarantee histologically normal endometrium in patients taking oestrogens without progestogen, and the incidence of adenomatous and atypical hyperplasia is significantly reduced by a progestogens when taken for 10 or more days monthly.
PubMedNoncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study.
180 Citations1987D B Petitti, Jeffrey A. Perlman +1 more
Data from a ten- to 13-year mortality follow-up of the 3437 women enrolled in the Walnut Creek Contraceptive Drug Study suggested that life-style differences between estrogen users and nonusers account at least in part for their lower mortality.
American Journal of Obstetrics and GynecologyA randomized comparison of nonoral estradiol delivery in postmenopausal women
169 Citations1988Frank Z. Stanczyk, Donna Shoupe +4 more
There was a significant increase in high-density lipoprotein cholesterol and a decrease in total cholesterol/high-density lipid cholesterol at 12 weeks with the pellet but only at 24 weeks withThe patch, and the urinary calcium/creatinine ratio was reduced more consistently withThe pellet than with the patch.
The LancetORAL CONTRACEPTIVE USE AND BREAST CANCER RISK IN YOUNG WOMEN
159 Citations1989UKNATIONALCASECONTROLSTUDYGRO
New England Journal of MedicineAbsorption of Estrogens from Vaginal Creams
158 Citations1978Lee A. Rigg, Harold W. Hermann +1 more
The substantial intestinal conversion of estradiol to estrone, observed after oral administration of est radiol,3 is circumvented by intravaginal application, and this findings prompted us to investigate the potential for absorption of estrogenic substances contained in vaginal cream.
PubMedPrevention of bone mineral loss in postmenopausal women by norethisterone.
149 Citations1985Hossam Abdalla, D.M. Hart +3 more
There was significant protection against bone loss in the norethisterone group and there was no alteration in urinary hydroxyproline/creatinine ratio.
Obstetrics and GynecologyThe Role and Use of Progestogens
146 Citations1990Malcolm Whitehead, Tim Hillard +1 more
Based upon the available literature, it is believed that the enthusiasm for continuous combined therapy is premature and caution is urged in its use until further, more conclusive, data become available.
Obstetrical & Gynecological SurveyAmenorrhea and Endometrial Atrophy with Continuous Oral Estrogen and Progestogen Therapy in Postmenopausal Women
139 Citations1985Adam Magos, M. Brincat +4 more
An oral regimen of continuous conjugated equine estrogens and low-dose progestogen used to treat 95 nonhysterectomized postmenopausal women for up to 2.5 years was undertaken in an attempt to avoid the withdrawal bleeding and progestogenic side effects associated with conventional cyclical therapy with estrogen and progests, while simultaneously protecting the endometrium from estrogenic overstimulation.
New England Journal of MedicineA Simple Method for Determining the Optimal Dosage of Progestin in Postmenopausal Women Receiving Estrogens
138 Citations1986Malcolm Padwick, J. Pryse‐Davies +1 more
Progestin is often added to regimens of estrogen therapy in postmenopausal women to reduce the risk of endometrial hyperstimulation, but it may cause undesirable metabolic effects.
American Journal of Obstetrics and GynecologyLong-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women
135 Citations1987Jytte Jensen, Bente Juel Riis +3 more
It is concluded that percutaneous estrogen administration produces changes in total serum cholesterol and low-density lipoprotein cholesterol levels similar to those observed after oral estrogen administration, however, the magnitude and time course of the response seem to be modulated by the route of administration.
Journal of the Royal Society of MedicineEndometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen Therapy
130 Citations1979Malcolm Whitehead, John McQueen +2 more
The data suggested that progestogens protected the endometrium against estrogen-induced stimulation, although complete protection was not afforded.
PubMedUse of medroxyprogesterone acetate to prevent menopausal symptoms.
125 Citations1975Bullock Jl, Massey Fm +1 more
DMPA can be an effective alternate to estrogen therapy in selected menopausal patients and was determined by the patients' estimates of the frequency and severity of their hot flashes.
MaturitasPrevention of endometrial cancer with progestogens
124 Citations1986R. Don Gambrell
The progestogen challenge test was devised to identify post-menopausal women at greatest risk for adenocarcinoma of the endometrium and it was concluded that the use of this test will reduce the risk of endometrial cancer in both oestrogen-treated post- menopausal women and women with increased endogenous oestrogens.
European Journal of EndocrinologyMETABOLIC AND HORMONAL EFFECTS OF POST-MENOPAUSAL OESTROGEN REPLACEMENT TREATMENT
122 Citations1977Lars Wallentin, Ulf Larsson‐Cohn
The net effect on the risk of development of ischemic cardiovascular disease due to the change in plasma lipids induced by EE2 is uncertain and the plasma lipid changes during EV therapy might possibly retard the development of atherosclerosis.
American Journal of Obstetrics and GynecologyEvaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient
119 Citations1990Louis Weinstein, Chhanda Bewtra +1 more
American Journal of Obstetrics and GynecologyClinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol andd-norgestrel
111 Citations1978Daniel R. Mishell, Donald E. Moore +3 more
This method has the advantage of inhibition of ovulation and good control of bleeding without the disadvantage of producing some adverse metabolic effects.
MaturitasContinuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation
110 Citations1981B Staland
Treatment of menopausal symptoms with a combination of natural oestrogens and a gestagen, given continuously without interruption, has been found to have a good effect on menopausal Symptoms, at the same time as the endometrium is maintained or brought to an atrophic state.
BJOG An International Journal of Obstetrics & GynaecologyFive years with continuous combined oestrogen/ progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern
108 Citations1990Claus Christiansen, Bente Juel Riis
The aim is to study the effect of long‐term continuous combined oestrogen/progestogen therapy on calcium metabolism, lipoproteins, and bleeding pattern in early postmenopausal women.
MaturitasCompliance with hormonal replacement therapy
107 Citations1991Barry G. Wren, Lauren Brown
Sixty-one percent continued to take the therapy while 27% ceased, most often the reason for ceasing HRT was return of bleeding but a number of women expressed fear of developing cancer or other long term complications.
The LancetŒSTROGEN USE AND SURVIVAL IN ENDOMETRIAL CANCER
101 Citations1980John A. Collins, Lisa Allen +2 more
A history of œstrogen use is not associated with superior survival of women who have poorly differentiated tumours or myometrial invasion, and the risk of death from endometrial cancer is 5·4 times greater for non-users.
PubMedRe-evaluating the role of progestogen therapy after the menopause.
100 Citations1988Brian E. Henderson, R K Ross +3 more
It is concluded from this analysis that ERT is to be preferred to combination therapy for postmenopausal women without a uterus, primarily because it is predicted thatERT confers a significantly greater benefit on heart disease risk.
Archives of Internal MedicineEstrogen Replacement Therapy
95 Citations1989Kristi J. Ferguson
Assessment of women's attitudes toward ERT showed that women taking ERT were more likely to know that decreased estrogen levels lead to osteoporosis, to perceive that menopause is a medical condition, and to believe that natural approaches to menupause are less preferable.
PubMedEfficacy of a continuous estrogen-progestin regimen in the menopausal patient.
88 Citations1987L Weinstein
Results suggest that a continuous regimen of 0.625 mg conjugated equine estrogen with 2.5 mg medroxyprogesterone acetate is beneficial as a primary hormonal replacement therapy for the postmenopausal patient.
The LancetTransdermal administration of oestrogen/progestagen hormone replacement therapy
72 Citations1990Malcolm Whitehead, D.I. Fraser +3 more
Preliminary findings show that transdermal progestagen can be successfully administered in hormone replacement therapy to prevent endometrial proliferation while minimising the adverse effects that may be seen with oral administration.
Acta Obstetricia Et Gynecologica ScandinavicaTREATMENT OF POST‐MENOPAUSAL HYPERCHOLEROLAEMIA WITH ESTRADIOL
71 Citations1979Matti J. Tikkanen, T Kuusi +2 more
Replacement therapy with estradiol valerate in 29 post‐menopausal women reduced low‐density lipoprotein (LDL) cholesterol concentrations by 22% and increased high‐density cholesterol levels by 21% after 12 months, and it is suggested that Estradiol replacement therapy should be considered in climacteric women with high LDL‐cholesterol or low HDL‐ch cholesterol levels.
American Journal of Obstetrics and GynecologyContinuous estrogen/progestin therapy in menopause
69 Citations1987Stanley G. Prough, Sezer Aksel +2 more
It is suggested that continuous conjugated equine estrogen plus medroxyprogesterone acetate therapy appears to be a satisfactory method of postmenopausal hormone replacement, effectively reducing menopausal symptoms without any apparent short-term alterations in serum lipids.
American Journal of Obstetrics and GynecologyTransdermal estradiol overall safety profile
69 Citations1987Wulf H. Utian
PubMedDiethylstilbestrol and progesterone regulation of cultured rabbit endometrial cell growth.
65 Citations1974L. E. Gerschenson, J A Berliner +1 more
A new tissue culture system has been developed for the study of the effects of sexual hormones in endometrium, which induced the appearance of big, clear, multinucleated cells, derived apparently from the normal epithelial cells.
American Journal of Obstetrics and GynecologyA study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement
60 Citations1990Steven R. Williams, Barbara Frenchek +2 more
The continuous ethinyl estradiol-norethindrone acetate tablet provided the same salutary effects on bone, endometrium, and postmenopausal symptoms as sequential therapy while minimizing annoying vaginal bleeding and spotting.
PubMedPhysicians' judgments about estrogen replacement therapy for menopausal women.
59 Citations1984Gerald B. Holzman, Michael M. Ravitch +4 more
A study was undertaken to determine how physicians decide when to prescribe estrogen and found the constant, not factor weights, were significantly related to each physician's overall likelihood of prescribing and to the individual's self-characterization as presoiber or nonprescriber.
International Journal of CancerNon‐contraceptive oestrogens and the risk of breast cancer in women
58 Citations1986Carlo La Vecchia, Adriano Decarli +4 more
The relationship between use of non‐contraceptive oestrogens and risk of breast cancer was investigated using data from a hospital‐based case‐control study from Northern Italy, finding that the risk increased with duration of use, but was unrelated to time elapsed since first or last use.
MaturitasThe effect of type and dose of oestrogen on the blood pressure of post-menopausal women
58 Citations1983Barry G. Wren, Anthony D. Routledge
Evidence from two groups of post-menopausal women who were randomly allocated to be treated with either conjugated equine oestrogen or piperazine oestrone sulphate demonstrates that the two oestrogens produce markedly different effects on blood pressure.
BJOG An International Journal of Obstetrics & GynaecologyContinuous oestrogen‐progestogen treatment and serum lipoproteins in postmenopausal women
57 Citations1987Jytte Jensen, Bente Juel Riis +2 more
The addition of norethisterone acetate to postmenopausal oestrogen therapy in clinically relevant doses had no adverse effects on lipoproteins as previously reported, even though administered continuously.
New England Journal of MedicinePostmenopausal Estrogen Replacement and Breast Cancer
56 Citations1989Elizabeth Barrett‐Connor
An epidemiologic study in this issue of the Journal 1 could change the way the authors think about postmenopausal hormone replacement.
International Journal of EpidemiologyAssociation of Serum Low Density Lipoprotein Cholesterol, Smoking and Hypertension with Different Manifestations of Atherosclerosis
54 Citations1990Jukka T. Salonen, Riitta Salonen
It is suggested that elevated serum LDL cholesterol concentration associates with an increased risk of common carotid arterial wall thickening, whereas smoking is associated more strongly withcarotid plaques than intimal-medial thickening.
Obstetrical & Gynecological SurveyMenopausal Hormone Replacement Therapy with Continuous Daily Oral Micronized Estradiol and Progesterone
54 Citations1989Joel T. Hargrove, Wayne S. Maxson +2 more
This study demonstrates that the daily administration of a combination of micronized E2 and progesterone results in symptomatic improvement, minimal side effects, an improved lipid profile, and amenorrhea without endometrial proliferation or hyperplasia in menopausal women.
PubMedSubdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
53 Citations1980Rogerio A. Løbo, Charles M. March +3 more
American Journal of Obstetrics and GynecologyProposal to decrease the risk and improve the prognosis of breast cancer
52 Citations1984R. Don Gambrell
Estrogen therapy does not increase the risk of mammary malignancy, but added progestogen significantly decreases the risk.
The Climacteric in Perspective
51 Citations1986
It is never too late to benefit from an increase in physical activity and the best preventive medicine against some of the debilitating problems of old age may be an 'exercise prescription' for a lifetime of vigorous physical activity.
American Journal of Obstetrics and GynecologySubdermal estradiol pellets following hysterectomy and oophorectomy
50 Citations1980Rogerio A. Løbo, Charles M. March +3 more
E2 pellets are an effective form of parenteral estrogen replacement therapy and offer both practical and theorteical advantages over other forms of estrogen.
DICPUse of Estrogens among Middle-Aged Massachusetts Women
46 Citations1991Elina Hemminki, Donald Brambilla +2 more
It was shown that estrogen use increased throughout the study period and by the final follow-up women with higher education status reported more estrogen use than those with lower education status and most women used estrogens only for a short time.
PubMedClinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy.
46 Citations1988AA Luciano, Turksoy Rn +2 more
The data suggest that the combined and continuous use of conjugated equine estrogen and medroxyprogesterone acetate effectively relieves menopausal symptoms, decreases the frequency of uterine bleeding, induces endometrial atrophy, and significantly decreases serum levels of total cholesterol.
Obstetrics and GynecologyComparison of Continuous Versus Sequential Estrogen and Progestin Therapy in Postmenopausal Women
45 Citations1991Paul R. Clisham, DOMINIC de ZIEGLER +2 more
PubMedCompliance difficulties with progestin-supplemented estrogen replacement therapy.
43 Citations1984Robert G. Hahn, Nachtigall Rd +1 more
All but three women of the estrogen-progestin group elected to discontinue therapy because of undesirable "physiologic" withdrawal bleeding, and future progestin-ERT recommendations should take these results into consideration.
American Journal of Obstetrics and GynecologyBleeding patterns during continuous combined estrogen-progestogen therapy
42 Citations1991U. Marslew, Bente Juel Riis +1 more
It is concluded that a continuous combination of estrogen and progestogen can produce amenorrhea and symptomatic relief, however, the progestogenic components seem to differ in their ability to control bleeding.
Fertility and SterilityIs Provera the ideal progestogen for addition to postmenopausal estrogen therapy?
42 Citations1986Geoffrey K. Lane, N. C. SIDDLE +4 more
Both morphologically and biochemically, medroxyprogesterone acetate, even at high dosage, produced suboptimal responses, but the responses were variable and inconsistent.
Obstetrics and GynecologyMicronized 17β-Estradiol for Oral Estrogen Therapy in Menopausal Women
40 Citations1975MERRITT R. CALLANTINE, Purvis L. Martin +3 more
Micronized 17β-estradiol (E2) was used as oral replacement therapy in 369 patients with estrogen deficiency and related menopausal symptoms and gained satisfactory relief of their symptoms from cyclic E2 therapy.
BJOG An International Journal of Obstetrics & GynaecologyMENOPAUSAL HOT FLUSHES : A DOUBLE BLIND COMPARISON OF PLACEBO, ETHINYL OESTRADIOL AND NORGESTREL
40 Citations1978Lorraine Dennerstein, G. D. Burrows +2 more
Journal of Clinical InvestigationEffects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women.
37 Citations1989B M Wolfe, Murray W. Huff
Treatment of postmenopausal women with low doses of estradiol-17 beta and dl-norgestrel significantly reduced fasting serum levels of low density cholesterol and lowered very low density lipoprotein (VLDL) triglycerides in four of five subjects.
PubMedEndometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin.
31 Citations1988Chhanda Bewtra, Kable Wt +1 more
A hormonal regimen that leads to reduced or absent bleeding and an inactive endometrium is preferable for postmenopausal women if estrogen therapy is to be used for the long term after menopause.
MaturitasMenopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone
31 Citations1989JT Hargrove, Maxson Ws +2 more
Acta Obstetricia Et Gynecologica ScandinavicaESTROGEN‐PROGESTOGEN REPLACEMENT IN CLIMACTERIC WOMEN, PARTICULARLY AS REGARDS A NEW TYPE OF CONTINUOUS REGIMEN
29 Citations1985Lars‐Åke Mattsson, Göran Samsioe
Blood samples were collected before, after 3 months and after 12 months of treatment and were analysed for estradiol‐17‐β, estrone, androstenedione in serum and lipoprotein lipids.
MetabolismDifferential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate
24 Citations1980Maire T. Buckman, J.David Johnson +3 more
Despite substantial increases in serum estrogens, parenteral estrogen administration (depo-estradiol cypionate, 5 and 10 mg) failed to result in alterations in any of the measured parameters.
PubMedLipid changes after hormone replacement therapy for menopause.
24 Citations1990Warren T. Kable, John C. Gallagher +2 more
There was no significant difference in the response of the blood lipids to the three hormone groups, therefore, preference would depend on the combination that caused the least bleeding or amenorrhea.
MaturitasEffect of continuous oestradiol-medroxyprogesterone administration on plasma lipids and lipoproteins
23 Citations1991Antonio Cano, Humberto Fernandes +2 more
It seems clear that an oestradiol and medroxyprogesterone combination administered continuously produces biochemical changes which are regarded as protective against cardiovascular disease and would warrant its use as a good alternative in post-menopausal replacement therapy.
Fertility and SterilitySerum lipids and lipoproteins in continuous or cyclic medroxyprogesterone acetate treatment in postmenopausal women treated with conjugated estrogens
19 Citations1990Michael K. Yancey, Charles J. Hannan +4 more
The 10 mg MPA group did not have an increase in HDL or decrease in low-density lipoprotein as did the other groups, and no differences in total cholesterol, high-density cholesterol, triglycerides, apolipoproteins I and II, sex hormone-binding globulin, or serum MPA levels were noted between the sequential and 5 mg continuous group.
MaturitasA novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy
17 Citations1989T Sporrong, Göran Samsioe +2 more
Stochastic analysis of the bleeding data confirmed that women on the high progestogen doses experienced fewer bleeding episodes than those on the low doses and women who weighed under 67 kg or had had their last menstruation over 5 yr previously bled less than the other women in the high-dose groups.
PubMedImmunoreactive and estrogen-binding estrogen receptors, and progestin receptor levels in uterine leiomyomata and their parental myometrium.
14 Citations1990Stanisław J. Chrapusta, Bożena Konopka +3 more
D dissimilar distribution patterns of immunoreactive, estrogen-nonbinding ER in leiomyomata and normal myometria suggest that an impaired metabolism of ER may contribute to myoma growth.
Skin PharmacologyInfluence of the Size of the Area of Treatment on Percutaneous Absorption of Estradiol in the Rat
7 Citations2009J.F. Chanez, B. de Lignières +2 more
The influence of the dose, as well as the application area of topically applied 3H-estradiol in a volatile solution on its systemic bioavailability was investigated in hairless rats in vivo.
…